KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous use
offering product urn:matchory:offering:01m772jz1jeq5txazqmyep4m3m
Offered by Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity). Relation: not stated. Commodity: none confirmed.
An offering's identity is its owner, its commodity and its normalised name; it is never merged with another supplier's.
Facts
| Attribute | Value as written | Producer | Evidence | Observed | Status |
|---|---|---|---|---|---|
| Name as stated name | KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous use | products products 2 | KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous usehttps://www.merck.com/products/ |
2026-11-12 | current |
| Name as stated name | KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous use | extraction extract 3 | KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous usehttps://www.merck.com/products/ |
2026-11-12 | current |
| UNSPSC classification unspsc | no code (16 candidates considered) | classification unspsc 3 | 2026-11-12 | current |